Bucher James B 4
4 · Eliem Therapeutics, Inc. · Filed Nov 2, 2022
Insider Transaction Report
Form 4
Bucher James B
EVP and General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2022-10-31+95,000→ 95,000 totalExercise: $3.27Exp: 2032-10-30→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "2022 Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2022 Vesting Commencement Date.